Fibrinogen is a risk factor for women
This article was originally published in Clinica
Executive Summary
Raised levels of the clotting factor, fibrinogen, put young women as well as men at risk of heart attacks, says a group of Swedish and US researchers. Fibrinogen has been linked to heart disease in men for some time but until now the importance in women had been unclear. Speaking at the ACC, Dr Margita Eriksson, from the Karolinska Hospital in Sweden, said this is because women tend not to experience heart disease until later in life than men. "They are older, have more hypertension and suffer higher acute mortality," she said.
You may also be interested in...
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.